We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Artificial Intelligence Add-On for `World’s First` Portable MR Imaging System Receives FDA Clearance

By MedImaging International staff writers
Posted on 19 Jan 2021
Print article
Image: Swoop Portable MR Imaging System (Photo courtesy of Hyperfine Research, Inc.)
Image: Swoop Portable MR Imaging System (Photo courtesy of Hyperfine Research, Inc.)
Hyperfine Research, Inc. (Guilford, CT, USA) has received 510(k) clearance from the US FDA for its deep-learning image analysis software that measure brain structure and pathology in images acquired by the Swoop Portable MR Imaging System.

Magnetic Resonance Imaging (MRI) uses a magnetic field, radio waves, and a computer to produce detailed pictures of the body's internal structures that are clearer, more detailed, and more likely in some instances to identify and accurately characterize disease than other imaging methods. However, fixed MRI systems can be inconvenient and inaccessible for providers and patients, particularly when time is critical. Transport to the MR suite demands complicated scheduling coordination, moving patients, and, often, 4- to 6-hour patient backlogs — all of which compromise the utility of MRI as a diagnostic tool in time-sensitive settings, such as intensive care units and emergency rooms. Furthermore, high capital investments, electrical power needs, and significant maintenance requirements present barriers to adoption across all populations, acutely so for developing countries and rural geographies.

Hyperfine’s Swoop Portable MR Imaging System is designed to address the limitations of current imaging technologies and make MRI accessible anytime, anywhere, to any patient. Swoop wheels directly to the patient’s bedside, plugs into a standard electrical wall outlet, and is controlled by an Apple iPad. Designed as a complementary system to traditional MRIs at a fraction of the cost, images that display the internal structure of the head are captured by Swoop at the patient’s bedside, with results in minutes. Included as part of Swoop’s standard software package, Advanced AI Applications work with Swoop to transform the system into a true bedside clinical decision support platform for evaluating brain health and injury. In just minutes after Swoop scanning, Advanced AI Applications analyze and return annotated and segmented brain images, providing clinicians of all levels of expertise with quantitative markers for decision support and immediate feedback for diagnostic insight.

“With this powerful tool now built into the Swoop system, we are making MR imaging not only accessible at the bedside but making it easier for providers to move quickly from scan to a recommended course of treatment,” said Dr. Khan Siddiqui, Chief Medical Officer of Hyperfine. “The data provided by Hyperfine's deep learning software will liberate users of our MR technology by providing simple, accessible information in just minutes.”

Related Links:
Hyperfine Research, Inc.

New
Prostate Cancer MRI Analysis Tool
DynaCAD Urology
Portable Color Doppler Ultrasound Scanner
DCU10
Wall Fixtures
MRI SERIES
Silver Member
X-Ray QA Meter
T3 AD Pro

Print article

Channels

MRI

view channel
Image: An AI tool has shown tremendous promise for predicting relapse of pediatric brain cancer (Photo courtesy of 123RF)

AI Tool Predicts Relapse of Pediatric Brain Cancer from Brain MRI Scans

Many pediatric gliomas are treatable with surgery alone, but relapses can be catastrophic. Predicting which patients are at risk for recurrence remains challenging, leading to frequent follow-ups with... Read more

Nuclear Medicine

view channel
Image: In vivo imaging of U-87 MG xenograft model with varying mass doses of 89Zr-labeled KLG-3 or isotype control (Photo courtesy of L Gajecki et al.; doi.org/10.2967/jnumed.124.268762)

Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors

Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.